{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:39:30Z","timestamp":1773779970042,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.eplepsyres.2011.04.001","type":"journal-article","created":{"date-parts":[[2011,5,9]],"date-time":"2011-05-09T06:20:39Z","timestamp":1304922039000},"page":"277-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["No effect of oral contraceptives on the metabolism of levetiracetam"],"prefix":"10.1016","volume":"95","author":[{"given":"Anne","family":"Sabers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2011.04.001_bib0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0920-1211(02)00135-3","article-title":"Information recalled by women taking anti-epileptic drugs for epilepsy: a questionnaire study","volume":"52","author":"Bell","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2011.04.001_bib0010","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1528-1167.2007.00997.x","article-title":"Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial","volume":"48","author":"Christensen","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2011.04.001_bib0015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/13625180802511541","article-title":"Women's contraceptive practices and sexual behaviour in Europe","volume":"13","author":"Cibula","year":"2008","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.eplepsyres.2011.04.001_bib0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00007691-199212000-00012","article-title":"A liquid chromatographic assay using a high-speed column for the determination of lamotrigine, a new antiepileptic drug, in human plasma","volume":"14","author":"Fazio","year":"1992","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.eplepsyres.2011.04.001_bib0025","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/01.WNL.0000123695.22623.32","volume":"62","author":"French","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2011.04.001_bib0030","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1528-1167.2006.00629.x","article-title":"Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy","volume":"47","author":"Galimberti","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2011.04.001_bib0035","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1212\/01.wnl.0000344167.78102.f0","article-title":"Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use","volume":"72","author":"Herzog","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2011.04.001_bib0040","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1528-1167.2007.01043.x","article-title":"Effect of age and comedication on levetiracetam pharmacokinetics and tolerability","volume":"48","author":"Hirsch","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2011.04.001_bib0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yebeh.2004.11.006","article-title":"Knowledge of women's issues and epilepsy (KOWIE-II): a survey of health care professionals","volume":"6","author":"Long","year":"2005","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2011.04.001_bib0050","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/00007691-200312000-00007","article-title":"Serum concentrations of levetiracetam in epileptic patients: the influence of dose and co-medication","volume":"25","author":"May","year":"2003","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.eplepsyres.2011.04.001_bib0055","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.yebeh.2009.04.026","article-title":"Antiepileptic drug use in women of childbearing age","volume":"15","author":"Meador","year":"2009","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2011.04.001_bib0060","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","article-title":"Clinical pharmacokinetics of levetiracetam","volume":"43","author":"Patsalos","year":"2004","journal-title":"Clin. Pharmacokinet."},{"issue":"Suppl. 1","key":"10.1016\/j.eplepsyres.2011.04.001_bib0065","first-page":"S17","article-title":"The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come?","volume":"5","author":"Perucca","year":"2003","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.eplepsyres.2011.04.001_bib0070","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1528-1157.2002.57701.x","article-title":"Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women","volume":"43","author":"Ragueneau-Majlessi","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2011.04.001_bib0075","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1212\/01.WNL.0000076485.09353.7A","article-title":"Oral contraceptives reduce lamotrigine plasma levels","volume":"61","author":"Sabers","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2011.04.001_bib0080","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1528-1167.2007.01032.x","article-title":"Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation","volume":"48","author":"Tomson","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2011.04.001_bib0085","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.seizure.2007.11.027","article-title":"Serum concentration\/dose ratio of levetiracetam before, during and after pregnancy","volume":"17","author":"Westin","year":"2008","journal-title":"Seizure"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121111000891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121111000891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:25:38Z","timestamp":1760275538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121111000891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0920121111000891"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2011.04.001","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No effect of oral contraceptives on the metabolism of levetiracetam","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2011.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}